Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Open-market sale Exec. VP Chief Legal Officer sold 65,312 shares at $12.69 ($829,103)
  2. 4 Grant or award President and CEO acquired 226,173 shares (grant or award)
  3. 4 Grant or award See "Remarks" below acquired 65,339 shares (grant or award)
  4. 4 Open-market sale EVP, North America Commercial sold 20,694 shares at $12.69 ($262,700)
  5. 4 Open-market sale EVP, International Markets sold 21,635 shares at $12.72 ($275,217)
  6. 4 Open-market sale Executive VP, Global R&D sold 29,496 shares at $12.69 ($374,437)
  7. 4 Open-market sale Executive VP Global Operations sold 17,979 shares at $12.72 ($228,709)
  8. 4 Open-market sale EVP Global Marketing&Portfolio sold 29,657 shares at $12.69 ($376,481)
  9. 4 Open-market sale Exec. VP, European Commercial sold 68,422 shares at $12.72 ($870,389)
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Executive or director change
  14. 8-K Event Executive or director change
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4 Option exercise President and CEO acquired 392,314 shares (option exercise)
  18. 4 Open-market sale Exec. VP, European Commercial sold 333 shares at $8.98 ($2,992)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 33 of 128 · 2,555 filings